TRICCAR Steps Up With Global Assistance

TRICCAR is stepping up to help first responders, critical utilities workers, and essential government workers during the global COVID-19 pandemic. TRICCAR's will provide our AVL bioceutical supplement at cost during the global COVID-19 pandemic.  If you are a government, healthcare, law enforcement, fire, or utilities official seeking to help protect your workers  and are interested in providing TRICCAR's AVL antiviral supplement to your first responders, please contact us.

TO:  Governors, Mayors, and public leaders 

FROM: Bill Townsend, President & CEO, TRICCAR, Inc. 

RE:  Supporting your First Responders

DATE:  Thursday, April 16, 2020

   As of this morning, I know 19 people that have died from COVID-19. Never in my wildest imagination would I believe a virus could take the lives of so many friends in just three months. I know dozens of others who have become infected, including my niece and a cousin who is now connected to a ventilator in Los Angeles. While proactively preventing the spread of COVID-19 short of massive testing, travel restrictions, and quarantining entire cities, has proven difficult in America, we know that protection from influenza, RSV, rhinovirus and human coronavirus is possible, potentially creating a line of defense through enhanced immune system support as we head into summer and fall.

   A new report from the CDC says more than 9,000 health care workers have contracted the coronavirus in the U.S. and the United Food Workers reports that over 30 grocery workers have died. We truly are in unique and unprecedented times. 

   Moving forward, everyone needs to understand the risks of coronavirus recurrence, yet this has not been talked about in public policy due to the extremely fast spread of COVID-19. As Harvard University’s professor of epidemiology at the T.H. Chan School of Public Health, Dr. Marc Lipsitch, stated this week, “there's every reason to expect a resurgence of cases and we're back in the same problem.”  

   TRICCAR is a publicly-held biomedicine firm whose products are supported by over $67 million of clinical research. The TRICCAR team has clinical proof of the benefits of strengthening the human immune system. AVL™, our proprietary antiviral bioceutical, completed double-blind testing last month, demonstrating dramatic results: 89.5% of those taking AVL did not contract RSV, rhinovirus, or human coronavirus, and 95.3% did not contract the flu. The results suggest an easy and effective over-the-counter means to help people fight viruses; an important and vital benefit for first responders.

   Of note, three people in the control group tested positive for COVID-19 while none in the AVL group did. While we cannot claim that AVL blocks the COVID-19 virus, we feel confident in stating that AVL supports the human immune system and should be a part of every first responder’s regimen.*

   Government leaders have focused on the “physical” elements of public health, i.e., masks, gloves, hospital equipment, etc., all critical components of public health and safety; but, it is important for people on the front lines to add the “biological” prevention layer to remain healthy.

   We want to assist you in providing the men and women on the front lines—doctors, nurses, medical staff, law enforcement, utility workers, and leaders like yourself—our antiviral bioceutical at cost, making this protection available at a very affordable 53¢ a day.

   We stand ready to ramp production to provide your first responders, essential utility workers, and core government officials with 3-month supplies of AVL for just $48.61 plus delivery per person.

   We’d like to help provide every first responder, utilities worker, and critical government personnel have the opportunity to strengthen and enhance their immune system’s natural protective capabilities in this time of global pandemic. TRICCAR is foregoing profit in order to provide AVL at cost because when hundreds of thousands are becoming sick and tens of thousands are dying, profits must take a back seat to fulfilling our moral obligation to humankind. 

   AVL is easy to administer: Two tablets are taken morning and night with six or more ounces of water. With your purchase order, we can begin the production process at our manufacturing facilities to ensure your first responders, core utility workers and essential government personnel receive the highest quality, Made in the USA products. 

   We believe there is no better antiviral bioceutical available and this is why we decided to not sell it directly to the public at this time, and instead put all our resources behind providing AVL to those that need it most: first responders.

   Let’s face it: China, Spain, and Italy have taught us COVID-19 is not going to magically disappear in the next 90 days. It may come roaring back after a lull, which the scientific community in China has been reporting, and can easily be reintroduced to the public through travel and social interaction. Providing your first responders a clinically proven and verified antiviral may help keep their immune systems functioning to better combat viruses and TRICCAR wants to help achieve this goal. 

   We would like to set up a call with you as soon as possible. Please ask your Chief of Staff or appropriate personnel to contact me at Hope @ TRICCAR . com or 1-833-384-HOPE. 

Bill Townsend

President & CEO

TRICCAR, Inc.
 

AVL™ Antiviral Immunity Support

Viral illnesses affect millions of people every year, resulting in lost income, high medical costs, lower quality of life, employment issues, and at times, loss of life.

Viruses can evolve much more quickly than the immune system can, which gives them an advantage in uninterrupted reproduction. Some viruses work essentially by tricking the immune system. Viruses cause many diseases, including, colds, flu, measles, chicken pox, HPV, herpes, rabies, SARS, MERS, and COVID-19.

Viruses and other germs are often highly contagious from person to person and capable of causing a significant spread of illness and long-term health problems.

Science has proven a direct relationship exists between increasing age and susceptibility to viral infections. Certain infections result in important risk factors for the elderly because the illnesses they cause increase the risk of death and are at times fatal.

The species of bacteria that colonize our respiratory and digestive systems help set up checks and balances in the immune system. Some species of bacteria can result in diseases, such as cancer, diabetes, cardiovascular disease, and obesity. Bad bacteria can exist at low levels in your body without causing harm or can grow too much and wreak havoc. Staphylococcus aureus can cause something as simple as a pimple or as serious as pneumonia or toxic shock syndrome. P. gingivalis can cause gum disease, and was recently linked to pancreatic cancer. Similarly, when not suppressed by good bacteria, Klebsiella pneumonia can cause colitis, and subsequently lead to colorectal cancer.  Recently, the COVID-19 coronavirus has spread worldwide, causing widespread illness, pulmonary fibrosis, and tens of thousands of deaths.

Benefits of AVL™:

AVL supports the human immune system:*

• In a 118 participant double-blind, placebo-based study conducted October 2019–March 2020, 89.5% of those taking AVL did not contract RSV, rhinovirus, or human coronavirus, compared to 40.6% in the control group taking placebo (10.5% vs. 40.6%). 

• Only 4.7% of those taking AVL contracted influenza (flu) compared to 24.1% in the control. 

• Three people in the control group tested positive for COVID-19 while none in the AVL group did. 

• Contains 18 natural antioxidant, antibacterial and antifungal ingredients.

• Stimulates the immune system by increasing the amount of probiotic bacteria in the gut as it undergoes fermentation.*

• Reduces the formation of free radicals in the body, protecting cells and molecules from damage.*

• Helps soothe gastrointestinal problems.*

• Boosts immune health, reduces risk of age-related diseases, and speeds wound healing.*

• Reduces oxidative stress associated with inflammation.*

• Anti-apoptotic.*

Serving Size:

2 tablets taken in the AM and PM with 6+ ounces of water. 

*These statements have not been evaluated by the Food and Drug Administration.  This product is not intended to diagnose, treat, cure, or prevent any disease. 

Do not use if pregnant or breastfeeding. 

TRICCAR, the TRICCAR logo, AVL,  and Polyamorphic Hipotomanine are trademarks of TRICCAR, Inc. 

TRICCAR's global network of FDA-approved personal protection equipment manufacturers is available to assist governments and non-government organizations. Please contact Mr. Christopher Johnson for details and quotes.